Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Dr. Jonathan Lim | Insider | 32.355.576 | 10,40% | US$ 426,45M | 2026-04-15 |
| Frazier Life Sciences Management, LP | Institution | 24.675.188 | 7,93% | US$ 325,22M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 23.074.986 | 7,42% | US$ 304,13M | 2026-03-31 |
| BlackRock, Inc. | Institution | 20.151.406 | 6,48% | US$ 265,60M | 2026-03-31 |
| VR Management, LLC | Institution | 16.216.216 | 5,21% | US$ 213,73M | 2026-04-15 |
| RTW Investments, LP | Institution | 16.157.175 | 5,20% | US$ 212,95M | 2026-03-31 |
| Venrock Healthcare Capital Partners EG, L.P. | Institution | 13.378.378 | 4,30% | US$ 176,33M | 2026-04-15 |
| Paradigm BioCapital International Fund Ltd. | Institution | 13.377.027 | 4,30% | US$ 176,31M | 2026-01-07 |
| Novartis AG | Institution | 12.307.692 | 3,96% | US$ 162,22M | 2024-12-31 |
| Vivo Capital, LLC | Institution | 12.151.480 | 3,91% | US$ 160,16M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 11.249.738 | 3,62% | US$ 148,27M | 2026-03-31 |
| Artal Group S.A. | Institution | 11.244.246 | 3,62% | US$ 148,20M | 2026-03-31 |
| Logos Global Management, L.P. | Institution | 11.150.000 | 3,59% | US$ 146,96M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 10.392.702 | 3,34% | US$ 136,98M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 9.300.084 | 2,99% | US$ 122,58M | 2026-03-31 |
| Arch Venture Partners, L.P. | Institution | 7.091.557 | 2,28% | US$ 93,47M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 5.996.149 | 1,93% | US$ 79,03M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 5.800.000 | 1,87% | US$ 76,44M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 5.350.000 | 1,72% | US$ 70,51M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 5.143.985 | 1,65% | US$ 67,80M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 3.710.966 | 1,19% | US$ 48,91M | 2026-03-31 |
| 5AM Venture Management, LLC | Institution | 3.485.971 | 1,12% | US$ 45,95M | 2026-03-31 |
| Suvretta Capital Management, LLC | Institution | 3.434.967 | 1,10% | US$ 45,27M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 3.254.019 | 1,05% | US$ 42,89M | 2026-03-31 |
| Commodore Capital LP | Institution | 3.175.000 | 1,02% | US$ 41,85M | 2026-03-31 |
| Averill Master Fund, Ltd. | Institution | 2.945.497 | 0,95% | US$ 38,82M | 2026-03-31 |
| Bank of America Corporation | Institution | 2.889.329 | 0,93% | US$ 38,08M | 2026-03-31 |
| Andreessen Horowitz LLC | Institution | 2.862.500 | 0,92% | US$ 37,73M | 2026-03-31 |
| Woodline Partners LP | Institution | 2.831.538 | 0,91% | US$ 37,32M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 2.644.920 | 0,85% | US$ 34,86M | 2026-03-31 |
| Venrock Healthcare Capital Partners III, L.P. | Institution | 2.580.000 | 0,83% | US$ 34,00M | 2026-04-15 |
| UBS Asset Management AG | Institution | 2.107.587 | 0,68% | US$ 27,78M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 2.100.000 | 0,68% | US$ 27,68M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 1.898.224 | 0,61% | US$ 25,02M | 2026-03-31 |
| Silverarc Capital Management, LLC | Institution | 1.851.812 | 0,60% | US$ 24,41M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 1.786.389 | 0,57% | US$ 23,54M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 1.773.757 | 0,57% | US$ 23,38M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 1.701.623 | 0,55% | US$ 22,43M | 2026-03-31 |
| Victory Capital Management Inc. | Institution | 1.654.497 | 0,53% | US$ 21,81M | 2026-03-31 |
| Goldman Sachs Asset Management, L.P. | Institution | 1.621.167 | 0,52% | US$ 21,37M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 1.537.915 | 0,49% | US$ 20,27M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
